Introduction

This World Wide Web site is provided as a public service by Keryx Biopharmaceuticals. All information that Keryx provides at this site is considered private. Any information contained within this site may not be distributed or copied, reproduced or used in any manner, without the expressed written consent of Keryx Biopharmaceuticals. Use of the Keryx image and logo are registered trademarks of Keryx Biopharmaceuticals and may not be used or reproduced without the written consent of Keryx Biopharmaceuticals.

Information Collected From E-Mail

If you identify yourself by sending an E-mail containing personal information: You may volunteer to provide us personally identifying information, for example your mailing address, in an electronic mail message. Before you do so, you should know that the material you submit may be seen by various people. We may enter the information into a database and we may share it with other government agencies. Also, e-mail is not necessarily secure against interception. If your communication is very sensitive or includes personal information, you may want to send it in by postal mail instead. Information collected in this manner may be used for responding to requests for information as well as other authorized purposes.

Security, Intrusion and Detection

For site security purposes, and to ensure that this service remains available to all users, all network traffic is monitored in order to identify unauthorized attempts to upload or change information, or otherwise cause damage or conduct criminal activity. To protect the system from unauthorized use and to ensure that the system is functioning properly, individuals using this computer system are subject to having all of their activities monitored and recorded by personnel authorized to do so by the FBI (and such monitoring and recording will be conducted). Anyone using this system expressly consents to such monitoring and is advised that if such monitoring reveals evidence of possible abuse or criminal activity, system personnel may provide the results of such monitoring to appropriate officials. Unauthorized attempts to upload or change information, or otherwise cause damage to this service, are strictly prohibited and may be punishable under applicable federal law.

Disclaimer for Hypertext Links

Neither Keryx Biopharmaceuticals nor its contributors are responsible for the content of any off-site pages that are referenced by or that reference the Keryx Biopharmaceuticals Home Page. The user specifically acknowledges that neither Keryx Biopharmaceuticals nor its contributors are responsible for any defamatory, offensive, misleading or illegal conduct of other users, links, or third parties and that the risk of injury from the foregoing rests entirely with the user.

Links from the Keryx Biopharmaceuticals Home Page on the World Wide Web to other sites, or from other sites to the Keryx Biopharmaceuticals Home Page, do not constitute an endorsement by Keryx Biopharmaceuticals. These links are for convenience only. It is the responsibility of the user to evaluate the content and usefulness of information obtained from other sites.

Disclaimer for Keryx Biopharmaceuticals Information
All information provided by Keryx Biopharmaceuticals on this Home Page is made available to provide immediate access for the convenience of interested persons. While Keryx Biopharmaceuticals believes the information to be reliable, human or mechanical error remains a possibility. Therefore, Keryx Biopharmaceuticals does not guarantee the accuracy, completeness, timeliness, or correct sequencing of the information. Neither Keryx Biopharmaceuticals, nor any of the sources of the information, shall be responsible for any error or omission, or for the use of, or the results obtained from the use of, this information.

Disclaimer of Endorsement

Reference herein to any specific commercial products, processes, or services by trade name, trademark, manufacturer, or otherwise, does not constitute or imply its endorsement, recommendation, or favoring by the United States Government.

Disclaimer of SEC Content

The statements contained in this website that are not historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the expectations, beliefs, intentions or strategies regarding the future. Without limiting the foregoing, the words “anticipates”‚ “believes”‚ “expects”‚ “intends”‚ “may”‚ and “plans”‚ and similar expressions are intended to identify forward-looking statements. The Company intends that all forward-looking statements be subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the Company’s views as of the date they are made with respect to future events, but are subject to many risks and uncertainties, which could cause the actual results of the Company to differ materially from any future results expressed or implied by such forward-looking statements. For example, the results obtained in pre-clinical or clinical studies may not be indicative of results that will be obtained in future clinical trials, and delays in the initiation or completion of clinical trials may occur as a result of many factors. Further examples of such risks and uncertainties also include, but are not limited to: the obtaining of sufficient financing to maintain the Company’s planned operations, timely development, receipt of necessary regulatory approvals, and acceptance of new products; the successful application of the Company’s technology to produce new products; the obtaining of proprietary protection for any such technology and products; the impact of competitive products and pricing and reimbursement policies; and changing market conditions. The Company does not undertake to update forward-looking statements. Although the Company believes that the forward-looking statements contained herein are reasonable, it can give no assurances that the Company’s expectations are correct. All forward looking statements are expressly qualified in their entirety by this cautionary statement and other factors detailed in the Company’s reports filed with the Securities and Exchange Commission.